The World Federation of Hemophilia (WFH) 2010 World Congress held in Buenos Aires, Argentina, in July 2010, attracted more than 4,300 participants from 106 countries. This report summarizes two symposia held during the congress. The first, titled "Emerging Co-Morbidities in the Aging Hemophilia Population: Healthcare Challenges and Treatment Opportunities," chaired by Gerry Dolan, MD, and Jussara Almeida Cruz, MD, examined the co-morbidities experienced by the aging hemophilic patient population, such as cardiovascular disease, cancer, arthritis, osteoporosis, hypertension, and obesity. In addition, Bayer's products in preclinical and clinical development were reviewed, including a novel factor VIIa variant and a long-acting factor VIII molecule, i.e., one that has undergone site-specific PEGylation (attachment of polyethylene glycol [PEG] polymer chains to another molecule). The other symposium, titled "Practical Steps to Making Better Care for Hemophilia Patients a Reality," chaired by Carmen Altisent, MD, and Cesar Guerrero, RN, reviewed the steps that hemophilia caregivers can take to improve the care of their patients. Issues such as the treatment of hemarthroses, the role of the research nurse, and the management of pediatric patients transitioning to adulthood were discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12325-012-0010-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hip Arthroscopy After Total Hip Arthroplasty Is Rare (0.04%) and May be Contralateral.
Arthrosc Sports Med Rehabil
December 2024
Cedars Sinai Kerlan Jobe Institute, Los Angeles, California, U.S.A.
Purpose: To determine the patient demographics and incidence of hip arthroscopy after total hip arthroplasty using the PearlDiver database.
Methods: This is a retrospective study of patients undergoing total hip arthroplasty and arthroscopic hip surgery. The PearlDiver Claims Database was queried using Current Procedural Terminology (CPT) codes for records from 2010 to 2021.
Dr. Joan Venes: A Pioneer of Pediatric Neurosurgery.
Neurosurgery
January 2025
Department of Neurological Surgery, University of California San Diego, San Diego, California, USA.
Dr. Joan Venes (1935-2010) is a well-respected pioneer of pediatric neurosurgery. She was the third board-certified female neurosurgeon in the United States and was the first female neurosurgery resident to be accepted by her residency program at Yale University.
View Article and Find Full Text PDFUse of nicotine products, prescription drug products, and other methods to stop smoking by US adults in the 2022 National Health Interview Survey.
Intern Emerg Med
January 2025
Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, USA.
Article Synopsis
- A recent CDC survey analyzed methods used by US adults to stop smoking, showing that around 2.9 million adults successfully quit for at least 6 months in the last year.
- Most successful quitters were younger, educated, male, non-Hispanic White, and commonly used nicotine products, especially e-cigarettes, compared to less popular options like prescription drugs.
- The study highlights that many adults still try to quit smoking without support, suggesting a need for targeted interventions to help those who struggle the most in quitting, using proven methods.
Identifying mild traumatic brain injury in the post-acute polytrauma setting: a scoping review of diagnostic approaches and screening tools.
Brain Inj
January 2025
St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Objective: Mild traumatic brain injury (mTBI) is frequently overlooked in polytrauma patients due to the overshadowing of more severe injuries, a fact that makes its identification in post-acute settings challenging since symptoms overlap with other conditions and no validated diagnostic tools exist. To address this gap, this scoping review explored the literature on mTBI diagnosis in post-acute civilian polytrauma settings.
Methods: By utilizing the Arksey and O'Malley framework and PRISMA-ScR guidelines, the review focused on studies from 2010 to 2024 related to delayed mTBI diagnosis in adults.
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
EClinicalMedicine
December 2024
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Article Synopsis
- Pathologist assessment of tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancer shows variability, but AI could standardize and enhance TIL scoring for better prognostic outcomes.
- Ten AI models were tested for their analytical and prognostic validity using tissue samples from TNBC patients in both retrospective and prospective cohorts, revealing notable differences in performance across models.
- Most AI models demonstrated significant prognostic validity related to anti-tumor immunity, suggesting that leveraging AI could improve clinical understanding and outcomes in TNBC patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!